INDEXIQ ETF TR - IQ S&P HGH YLD (HYLV)

CUSIP: 45409B412

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / IQ S&P HGH YLD
Total 13F shares
3,427,289
Share change
-91,216
Total reported value
$85,519,095
Price per share
$24.95
Number of holders
29
Value change
-$2,273,899
Number of buys
9
Number of sells
16

Quarterly Holders Quick Answers

What is CUSIP 45409B412?
CUSIP 45409B412 identifies HYLV - INDEXIQ ETF TR - IQ S&P HGH YLD in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of INDEXIQ ETF TR - IQ S&P HGH YLD (HYLV) as of Q1 2021

As of 31 Mar 2021, INDEXIQ ETF TR - IQ S&P HGH YLD (HYLV) was held by 29 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,427,289 shares. The largest 10 holders included NEW YORK LIFE INVESTMENT MANAGEMENT LLC, CITADEL ADVISORS LLC, MORGAN STANLEY, JANE STREET GROUP, LLC, GeoWealth Management, LLC, BANK OF AMERICA CORP /DE/, ENVESTNET ASSET MANAGEMENT INC, Centric Wealth Management, RAYMOND JAMES & ASSOCIATES, and TAP Consulting, LLC. This page lists 29 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.